Peptable

Comparison

Kisspeptin vs Retatrutide

Function

While Kisspeptin is a key regulator of the hypothalamic–pituitary–gonadal axis, controlling puberty and fertility; kisspeptin-10 also inhibits trophoblast invasion and tumor metastasis in experimental models339199, Retatrutide is an investigational agent that produces very large body-weight reductions in early trials by simultaneously engaging GLP-1R, GIPR, and GCGR to enhance satiety, energy expenditure, and glycemic control2575.

Mechanism

While Kisspeptin works as a family of peptides (eg, kisspeptin-10, -13, -14, -54) derived from the KISS1 precursor that activate G-protein–coupled receptor KISS1R (GPR54), triggering GnRH release and regulating pubertal onset and reproductive axis activity339199, Retatrutide is a triple incretin agonist peptide derived from a GIP backbone and engineered to activate GLP-1, GIP, and glucagon receptors, with non-natural residues and fatty-acid conjugation that confer long half-life and balanced multi-receptor signaling256575.

Receptor

Kisspeptin

KISS1R (GPR54) kisspeptin receptor33919943

Retatrutide

GLP-1 receptor (GLP1R), GIP receptor (GIPR), and glucagon receptor (GCGR) 256575

Organism or Origin

Kisspeptin

Endogenous human peptide products of the KISS1 gene9199

Retatrutide

Synthetic multi-agonist peptide inspired by human incretins and glucagon657580

Gene

Kisspeptin

KISS1

Retatrutide

Not assigned in the current dataset.

Summary

Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Kisspeptin is more often discussed in the realm of Reproductive health, whereas Retatrutide is more often associated with the realm of Metabolic and endocrine. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Kisspeptin leaning toward and Retatrutide leaning toward Metabolic regulation and Lipolysis and fat loss. Kisspeptin has a more natural endogenous origin, while Retatrutide is closer to synthetic analog background with Kisspeptin in Preclinical development and Retatrutide in Clinical phase 3. Kisspeptin takes the form of a linear peptide, whereas Retatrutide is closer to a peptide conjugate, while Kisspeptin carries amidation features, while Retatrutide instead reflects lipidation changes.

Sources

70Kisspeptin-10, rat, https://pubchem.ncbi.nlm.nih.gov/compound/Kisspeptin-10_-rat
91Kisspeptin - Wikipedia, https://en.wikipedia.org/wiki/Kisspeptin
99Kisspeptin-1 - an overview, https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/kisspeptin-1
25What is the mechanism of action of Retatrutide? - Patsnap Synapse, https://synapse.patsnap.com/article/what-is-the-mechanism-of-action-of-retatrutide
65Retatrutide Molecular Structure and Properties | Peptide Protocol Wiki, https://www.peptideprotocolwiki.com/peptides/retatrutide/molecule
75Retatrutide: The Triple Hormone Agonist (GLP-1/GIP/Gluc, https://formblends.com/research/glp-1/retatrutide-triple-agonist-guide
80GLP-1 Localisation and Proglucagon Gene Expression in ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC6200298/